Forcing nonamyloidogenic β-synuclein to fibrillate

Biochemistry

Volumn 44, Issue 25, 2005, Pages 9096-9107

  Yamin, Ghiam ^a   Munishkina, Larissa A ^a   Karymov, Mikhail A ^b   Lyubchenko, Yuri L ^b   Uversky, Vladimir N ^a   Fink, Anthony L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; CELL CULTURE; CONFORMATIONS; DISEASES; NEUROLOGY; OLIGOMERS; PATHOLOGY; PESTICIDES;

FIBRILLATION; FIBRILS; LEWY BODIES; NEURODEGENERATIVE DISORDERS;

PROTEINS;

BETA SYNUCLEIN; COPPER; GLYCOSAMINOGLYCAN; LEAD; PESTICIDE; ZINC;

ARTICLE; CONFORMATIONAL TRANSITION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN FOLDING;

ALPHA-SYNUCLEIN; AMYLOID; BETA-SYNUCLEIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; COPPER; GLYCOSAMINOGLYCANS; HUMANS; LEAD; MICROSCOPY, ATOMIC FORCE; NERVE TISSUE PROTEINS; PESTICIDES; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; SOLVENTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SYNUCLEINS; ZINC;

EID: 21744444004     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi048778a     Document Type: Article

References (82)

1. Semchuk, K. M., Love, E. J., and Lee, R. G. (1993) Parkinson's disease: A test of the multifactorial etiologic hypothesis, Neurology 43, 1173-1180.
2. Uversky, V. N., Li, J., Zhu, M., Bower, K., and Fink, A. L. (2002) Synergistic effects of pesticides and metals on the fibrillation of α-synuclein: Implications for Parkinson's disease, Neurotoxicology 23, 527-536.
3. Forno, L. S. (1996) Neuropathology of Parkinson's disease, J. Neuropathol. Exp. Neurol. 55, 259-272.
4. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., and Goedert, M. (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies, Proc. Natl. Acad. Sci. U.S.A. 95, 6469-6473.
5. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997) α-Synuclein in Lewy bodies, Nature 388, 839-840.
6. Maroteaux, L., Campanelli, J. T., and Scheller, R. H. (1988) Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal, J. Neurosci. 8, 2804-2815.
7. Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., and Saitoh, T. (1993) Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A. 90, 11282-11286.
8. Jakes, R., Spillantini, M. G., and Goedert, M. (1994) Identification of two distinct synucleins from human brain, FEBS Lett. 345, 27-32.
9. George, J. M., Jin, H., Woods, W. S., and Clayton, D. F. (1995) Characterization of a novel protein regulated during the critical period for song learning in the zebra finch, Neuron 15, 361-372.
10. Nakajo, S., Tsukada, K., Omata, K., Nakamura, Y., and Nakaya, K. (1993) A new brain-specific 14-kDa protein is a phosphoprotein. Its complete amino acid sequence and evidence for phosphorylation, Eur. J. Biochem. 217, 1057-1063.
11. Ji, H., Liu, Y. E., Jia, T., Wang, M., Liu, J., Xiao, G., Joseph, B. K., Rosen, C., and Shi, Y. E. (1997) Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing, Cancer Res. 57, 759-764.
12. Buchman, V. L., Hunter, H. J., Pinon, L. G., Thompson, J., Privalova, E. M., Ninkina, N. N., and Davies, A. M. (1998) Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system, J. Neurosci. 18, 9335-9341.
13. Clayton, D. F., and George, J. M. (1998) The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease, Trends Neurosci. 21, 249-254.
14. Irizarry, M. C., Kim, T. W., McNamara, M., Tanzi, R. E., George, J. M., Clayton, D. F., and Hyman, B. T. (1996) Characterization of the precursor protein of the non-Aβ component of senile plaques (NACP) in the human central nervous system, J. Neuropathol. Exp. Neurol. 55, 889-895.
15. Conway, K. A., Harper, J. D., and Lansbury, P. T. (1998) Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease, Nat. Med. 4, 1318-1320.
16. Uversky, V. N., Lee, H. J., Li, J., Fink, A. L., and Lee, S. J. (2001) Stabilization of Partially Folded Conformation during α-Synuclein Oligomerization in Both Purified and Cytosolic Preparations, J. Biol. Chem. 276, 43495-43498.
17. Serpell, L. C., Berriman, J., Jakes, R., Goedert, M., and Crowther, R. A. (2000) Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation, Proc. Natl. Acad. Sci. U.S.A. 97, 4897-4902.
18. Hoyer, W., Antony, T., Cherny, D., Heim, G., Jovin, T. M., and Subramaniam, V. (2002) Dependence of α-synuclein aggregate morphology on solution conditions, J. Mol. Biol. 322, 383-393.
19. Goedert, M. (2001) Parkinson's disease and other α- synucleinopathies, Clin. Chem. Lab. Med. 39, 308-312.
20. Shibayama-Imazu, T., Okahashi, I., Omata, K., Nakajo, S., Ochiai, H., Nakai, Y., Hama, T., Nakamura, Y., and Nakaya, K. (1993) Cell and tissue distribution and developmental change of neuron specific 14 kDa protein (phosphoneuroprotein 14), Brain Res. 622, 17-25.
21. Nakajo, S., Shioda, S., Nakai, Y., and Nakaya, K. (1994) Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization, Brain Res. Mol. Brain Res. 27, 81-86.
22. Mori, F., Inenaga, C., Yoshimoto, M., Umezu, H., Tanaka, R., Takahashi, H., and Wakabayashi, K. (2002) α-Synuclein immunoreactivity in normal and neoplastic Schwann cells, Acta Neuropathol. 103, 145-151.
23. Galvin, J. E., Uryu, K., Lee, V. M., and Trojanowski, J. Q. (1999) Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains α-, β-, and γ-synuclein, Proc. Natl. Acad. Sci. U.S.A. 96, 13450-13455.
24. Uversky, V. N., Li, J., Souillac, P. O., Millett, I. S., Doniach, S., Jakes, R., Goedert, M., and Fink, A. L. (2002) Biophysical properties of the synucleins and their propensities to fibrillate: Inhibition of α-synuclein assembly by β- and γ-synucleins, J. Biol. Chem. 277, 11970-11978.
25. Park, J. Y., and Lansbury, P. T., Jr. (2003) β-Synuclein inhibits formation of α-synuclein protofibrils: A possible therapeutic strategy against Parkinson's disease, Biochemistry 42, 3696-3700.
26. Hashimoto, M., Rockenstein, E., Mante, M., Mallory, M., and Masliah, E. (2001) β-Synuclein inhibits α-synuclein aggregation: A possible role as an anti-parkinsonian factor, Neuron 32, 213-223.
27. Tanner, C. M. (1989) The role of environmental toxins in the etiology of Parkinson's disease, Trends Neurosci. 12, 49-54.
28. Gorell, J. M., Rybicki, B. A., Cole, J. C., and Peterson, E. L. (1999) Occupational metal exposures and the risk of Parkinson's disease, Neuroepidemiology 18, 303-308.
29. Zayed, J., Ducic, S., Campanella, G., Panisset, J. C., Andre, P., Masson, H., and Roy, M. (1990) Environmental factors in the etiology of Parkinson's disease, Can. J. Neurol. Sci. 17, 286-291.
30. Le Couteur, D. G., McLean, A. J., Taylor, M. C., Woodham, B. L., and Board, P. G. (1999) Pesticides and Parkinson's disease, Biomed. Pharmacother. 53, 122-130.
31. Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., and Richardson, R. J. (1998) The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living, Neurology 50, 1346-1350.
32. Semchuk, K. M., Love, E. J., and Lee, R. G. (1992) Parkinson's disease and exposure to agricultural work and pesticide chemicals, Neurology 42, 1328-1335.
33. Hertzman, C., Wiens, M., Snow, B., Kelly, S., and Calne, D. (1994) A case-control study of Parkinson's disease in a horticultural region of British Columbia, Movement Disord. 9, 69-75.
34. Hakansson, N., Gustavsson, P., Johansen, C., and Floderus, B. (2003) Neurodegenerative diseases in welders and other workers exposed to high levels of magnetic fields, Epidemiology 14, 420-426.
35. Dexter, D. T., Carayon, A., Javoy-Agid, F., Agid, Y., Wells, F. R., Daniel, S. E., Lees, A. J., Jenner, P., and Marsden, C. D. (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia, Brain 114 (Part 4), 1953-1975.
36. Hirsch, E. C., Brandel, J. P., Galle, P., Javoy-Agid, F., and Agid, Y. (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: An X-ray microanalysis, J. Neurochem. 56, 446-451.
37. Uversky, V. N., Li, J., and Fink, A. L. (2001) Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-Synuclein. A possible molecular link between Parkinson's disease and heavy metal exposure, J. Biol. Chem. 276, 44284-44296.
38. Goers, J., Uversky, V. N., and Fink, A. L. (2003) Polycation-induced oligomerization and accelerated fibrillation of human α-synuclein in vitro, Protein Sci. 12, 702-707.
39. Nielsen, L., Khurana, R., Coats, A., Frokjaer, S., Brange, J., Vyas, S., Uversky, V. N., and Fink, A. L. (2001) Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism, Biochemistry 40, 6036-6046.
40. Oberg, K., Chrunyk, B. A., Wetzel, R., and Fink, A. L. (1994) Nativelike secondary structure in interleukin-1β inclusion bodies by attenuated total reflectance FTIR, Biochemistry 33, 2628-2634.
41. Oberg, K. A., and Fink, A. L. (1998) A new attenuated total reflectance Fourier transform infrared spectroscopy method for the study of proteins in solution, Anal. Biochem. 256, 92-106.
42. Uversky, V. N. (1993) Use of fast protein size-exclusion liquid chromatography to study the unfolding of proteins which denature through the molten globule, Biochemistry 32, 13288-13298.
43. Uversky, V. N. (1994) Gel-permeation chromatography as a unique instrument for quantitative and qualitative analysis of protein denaturation and unfolding, Int. J. Biochem. 1, 103-114.
44. Shlyakhtenko, L. S., Gall, A. A., Filonov, A., Cerovac, Z., Lushnikov, A., and Lyubchenko, Y. L. (2003) Silatrane-based surface chemistry for immobilization of DNA, protein-DNA complexes and other biological materials, Ultramicroscopy 97, 279-287.
45. Paik, S. R., Shin, H. J., and Lee, J. H. (2000) Metal-catalyzed oxidation of α-synuclein in the presence of copper(II) and hydrogen peroxide, Arch. Biochem. Biophys. 378, 269-277.
46. Yamin, G., Glaser, C. B., Uversky, V. N., and Fink, A. L. (2003) Certain Metals Trigger Fibrillation of Methionine-oxidized α-Synuclein, J. Biol. Chem. 278, 27630-27635.
47. Naiki, H., Higuchi, K., Matsushima, K., Shimada, A., Chen, W. H., Hosokawa, M., and Takeda, T. (1990) Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: Use of the fluorescent indicator, thioflavine T, Lab. Invest. 62, 768-773.
48. Souillac, P. O., Uversky, V. N., Millett, I. S., Khurana, R., Doniach, S., and Fink, A. L. (2002) Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation: Evidence for an off-pathway oligomer at acidic pH, J. Biol. Chem. 277, 12657-12665.
49. Khurana, R., Ionescu-Zanetti, C., Pope, M., Li, J., Nielson, L., Ramirez-Alvarado, M., Regan, L., Fink, A. L., and Carter, S. A. (2003) A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy, Biophys. J. 85, 1135-1144.
50. Munishkina, L. A., Phelan, C., Uversky, V. N., and Fink, A. L. (2003) Conformational Behavior and Aggregation of α-Synuclein in Organic Solvents: Modeling the Effects of Membranes, Biochemistry 42, 2720-2730.
51. Uversky, V. N., Yamin, G., Souillac, P. O., Goers, J., Glaser, C. B., and Fink, A. L. (2002) Methionine oxidation inhibits fibrillation of human α-synuclein in vitro, FEBS Lett. 517, 239-244.
52. Yamin, G., Uversky, V. N., and Fink, A. L. (2003) Nitration inhibits fibrillation of human α-synuclein in vitro by formation of soluble oligomers, FEBS Lett. 542, 147-152.
53. Minton, A. P. (1997) Influence of excluded volume upon macromolecular structure and associations in "crowded" media, Curr. Opin. Biotechnol. 8, 65-69.
54. Minton, A. P. (2000) Implications of macromolecular crowding for protein assembly, Curr. Opin. Struct. Biol. 10, 34-39.
55. Zimmerman, S. B., and Minton, A. P. (1993) Macromolecular crowding: Biochemical, biophysical, and physiological consequences, Annu. Rev. Biophys. Biomol. Struct. 22, 27-65.
56. Minton, A. P. (2001) The influence of macromolecular crowding and macromolecular confinement on biochemical reactions in physiological media, J. Biol. Chem. 276, 10577-10580.
57. Hatters, D. M., Minton, A. P., and Hewlett, G. J. (2002) Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II, J. Biol. Chem. 277, 7824-7830.
58. Uversky, V. N., Cooper, M., Bower, K. S., Li, J., and Fink, A. L. (2002) Accelerated α-synuclein fibrillation in crowded milieu, FEBS Lett. 515, 99-103.
59. Munishkina, L. A., Cooper, E. M., Uversky, V. N., and Fink, A. L. (2004) The effect of macromolecular crowding on protein aggregation and amyloid fibril formation, J. Mol. Recognit. 17, 456-464.
60. Shtilerman, M. D., Ding, T. T., and Lansbury, P. T., Jr. (2002) Molecular crowding accelerates fibrillization of α-synuclein: Could an increase in the cytoplasmic protein concentration induce Parkinson's disease? Biochemistry 41, 3855-3860.
61. Kisilevsky, R. (2000) The relation of proteoglycans, serum amyloid P and apo E to amyloidosis current status, 2000, Amyloid 7, 23-25.
62. McLaurin, J., Franklin, T., Zhang, X., Deng, J., and Fraser, P. E. (1999) Interactions of Alzheimer amyloid-β peptides with glycosaminoglycans effects on fibril nucleation and growth, Eur. J. Biochem. 266, 1101-1110.
63. Snow, A. D., Willmer, J., and Kisilevsky, R. (1987) Sulfated Glycosaminoglycans: A Common Constituent of All Amyloids, Lab. Invest. 56, 120-123.
64. Cohlberg, J. A., Li, J., Uversky, V. N., and Fink, A. L. (2002) Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from α-synuclein in vitro. Biochemistry 41, 1502-1511.
65. Tanner, C. M., Chen, B., Wang, W. Z., Peng, M. L., Liu, Z. L., Liang, X. L., Kao, L. C., Gilley, D. W., and Schoenberg, B. S. (1987) Environmental factors in the etiology of Parkinson's disease, Can. J. Neurol. Sci. 14, 419-423.
66. Uversky, V. N., Li, J., and Fink, A. L. (2001) Pesticides directly accelerate the rate of α-synuclein fibril formation: A possible factor in Parkinson's disease, FEBS Lett. 500, 105-108.
67. Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., and Di Monte, D. A. (2002) The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice, J. Biol. Chem. 277, 1641-1644.
68. Iwatsubo, T., Yamaguchi, H., Fujimuro, M., Yokosawa, H., Ihara, Y., Trojanowski, J. Q., and Lee, V. M. Y. (1996) Purification and Characterization of Lewy Bodies from the Brains of Patients with Diffuse Lewy Body Disease. Am. J. Pathol. 148, 1517-1529.
69. Trojanowski, J. Q., Goedert, M., Iwatsubo, T., and Lee, V. M. (1998) Fatal attractions: Abnormal protein aggregation and neuron death in Parkinson's disease and lewy body dementia, Cell Death Differ. 5, 832-837.
70. Arawaka, S., Saito, Y., Murayama, S., and Mori, H. (1998) Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for α-synuclein, Neurology 51, 887-889.
71. Tu, P. H., Galvin, J. E., Baba, M., Giasson, B., Tomita, T., Leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J. Q., and Lee, V. M. (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein, Ann. Neurol. 44, 415-422.
72. Galvin, J. E., Giasson, B., Hurtig, H. I., Lee, V. M., and Trojanowski, J. Q. (2000) Neurodegeneration with brain iron accumulation, type 1 is characterized by α-, β-, and γ-synuclein neuropathology, Am. J. Pathol. 157, 361-368.
73. Mori, F., Nishie, M., Yoshimoto, M., Takahashi, H., and Wakabayashi, K. (2003) Reciprocal accumulation of β-synuclein in α-synuclein lesions in multiple system atrophy, NeuroReport 14, 1783-1786.
74. Mori, F., Hayashi, S., Yamagishi, S., Yoshimoto, M., Yagihashi, S., Takahashi, H., and Wakabayashi, K. (2002) Pick's disease: α- and β-synuclein-immunoreactive Pick bodies in the dentate gyrus, Acta Neuropathol. 104, 455-461.
75. Good, P. F., Olanow, C. W., and Perl, D. P. (1992) Neuromelanin- containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: A LAMMA study, Brain Res. 593, 343-346.
76. Yasui, M., Kihira, T., and Ota, K. (1992) Calcium, magnesium and aluminum concentrations in Parkinson's disease, Neurotoxicology 13, 593-600.
77. Goers, J., Manning-Bog, A. B., McCormack, A. L., Millett, I. S., Doniach, S., Di Monte, D. A., Uversky, V. N., and Fink, A. L. (2003) Nuclear Localization of α-Synuclein and Its Interaction with Histones, Biochemistry 42, 8465-8471.
78. Fandrich, M., Fletcher, M. A., and Dobson, C. M. (2001) Amyloid fibrils from muscle myoglobin, Nature 410, 165-166.
79. Pertinhez, T. A., Bouchard, M., Tomlinson, E. J., Wain, R., Ferguson, S. J., Dobson, C. M., and Smith, L. J. (2001) Amyloid fibril formation by a helical cytochrome. FEBS Lett. 495, 184-186.
80. Uversky, V. N., and Fink, A. L. (2004) Conformational constraints for amyloid fibrillation: The importance of being unfolded, Biochim. Biophys. Acta 1698, 131-153.
81. Yasui, M., Ota, K., and Garruto, R. M. (1993) Concentrations of zinc and iron in the brains of Guamanian patients with amyotrophic lateral sclerosis and parkinsonism-dementia, Neurotoxicology 14, 445-450.
82. Fredriksson, A., and Archer, T. (2003) Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: Behavioral enhancement by L-Dopa-MK-801 coadministration, Behav. Brain Res. 139, 31-46.